| 1. |
Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome[J]. Lancet, 1995, 346(8988): 1458-1463. DOI: 10.1016/s0140-6736(95)92473-6.
|
| 2. |
Pallotta MT, Tascini G, Crispoldi R, et al. Wolfram syndrome, a rare neurodegenerative disease: from pathogenesis to future treatment perspectives[J]. J Transl Med, 2019, 17(1): 238. DOI: 10.1186/s12967-019-1993-1.
|
| 3. |
Takeda K, Inoue H, Tanizawa Y, et al. WFS1(Wolfram syndrome 1) gene product: predominant subcellular localization to endoplasmic reticulum in cultured cells and neuronal expression in rat brain[J]. Hum Mol Genet, 2001, 10(5): 477-484. DOI: 10.1093/hmg/10.5.477.
|
| 4. |
Yamamoto H, Hofmann S, Hamasaki DI, et al. Wolfram syndrome 1(WFS1) protein expression in retinal ganglion cells and optic nerve glia of the cynomolgus monkey[J]. Exp Eye Res, 2006, 83(5): 1303-1306. DOI: 10.1016/j.exer.2006.06.010.
|
| 5. |
Cagalinec M, Liiv M, Hodurova Z, et al. Role of mitochondrial dynamics in neuronal development: mechanism for wolfram syndrome[J/OL]. PLoS Biol, 2016, 14(7): 1002511[2016-07-19]. http://europepmc.org/article/MED/27434582. DOI: 10.1371/journal.pbio.1002511.
|
| 6. |
Hoekel J, Narayanan A, Rutlin J, et al. Visual pathway function and structure in Wolfram syndrome: patient age, variation and progression[J/OL]. BMJ Open Ophthalmol 2018, 3(1): 000081[2018-01-18]. https://bmjophth.bmj.com/content/3/1/e000081. DOI: 10.1136/bmjophth-2017-000081.
|
| 7. |
Grenier J, Meunier I, Daien V, et al. WFS1 in optic neuropathies: mutation findings in nonsyndromic optic atrophy and assessment of clinical severity[J]. Ophthalmology, 2016, 123(9): 1989-1998. DOI: 10.1016/j.ophtha.2016.05.036.
|
| 8. |
Hoekel J, Chisholm SA, Al-Lozi A, et al. Ophthalmologic correlates of disease severity in children and adolescents with Wolfram syndrome[J]. J AAPOS, 2014, 18(5): 461-465. DOI: 10.1016/j.jaapos.2014.07.162.
|
| 9. |
Abreu D, Urano F. Current landscape of treatments for wolfram syndrome[J]. Trends Pharmacol Sci, 2019, 40(10): 711-714. DOI: 10.1016/j.tips.2019.07.011.
|
| 10. |
Bababeygy SR, Wang MY, Khaderi KR, et al. Visual improvement with the use of idebenone in the treatment of Wolfram syndrome[J]. J Neuroophthalmol, 2012, 32(4): 386-389. DOI: 10.1097/WNO.0b013e318273c102.
|
| 11. |
Lu S, Kanekura K, Hara T, et al. A calcium-dependent protease as a potential therapeutic target for Wolfram syndrome[J]. Proc Natl Acad Sci USA, 2014, 111(49): 5292-5301. DOI: 10.1073/pnas.1421055111.
|
| 12. |
Urano F. Wolfram syndrome iPS cells: the first human cell model of endoplasmic reticulum disease[J]. Diabetes, 2014, 63(3): 844-846. DOI: 10.2337/db13-1809.
|
